Back Other STDs

Other STDs

Oral Tenofovir Does Not Reduce Herpes Virus Shedding

HIV positive people who took tenofovir (Viread, also in the Truvada and Atripla combination pills) as part of their antiretroviral regimen were no less likely to shed herpes simplex virus 1 or 2 (HSV-1 or HSV-2) than individuals using non-tenofovir regimens, according to research described in the January 14, 2011, issue of AIDS. These findings are notable because a recent microbicide study found that a tenofovir gel reduced the likelihood of HSV-2 infection.

Read more:

U.S. Sexually Transmitted Disease Rates Remain High, with a Resurgence of Syphilis among Gay Men

Rates of 3 sexually transmitted diseases (STDs) -- chlamydia, gonorrhea, and syphilis -- remain high in the U.S., according to the latest epidemiological data issued last week in a report by the Centers for Disease Control and Prevention (CDC). These infections can be cured, but can cause serious complications if untreated and can increase the risk of HIV acquisition and transmission. High STD rates among African-Americans and teens are particularly alarming, and men who have sex with men account for the greatest prevalence of syphilis, which has made a comeback after nearly being eliminated.

Read more: